₹ 159.38₹ 159.38
In Short term fluid replacement after trauma Gelofusine EP 0.070gm/0.038gm/0.85gm Injection contains calcium chloride, sodium chloride and potassium chloride that protect the patient from dehydration and electrolyte disorders after any trauma or injury. Appropriate fluid replacement is very essential to restore normal brain activity and other vital functions of the body to promote healing as well as speedy recovery.
Gelofusine EP 0.070gm/0.038gm/0.85gm Injection is a combination of three medicines. It is given as a short-term fluid replacement after trauma. Gelofusine EP 0.070gm/0.038gm/0.85gm Injection works by replenishing the body?s fluid and electrolytes. This injection should be administered under the supervision of a healthcare professional. You should not self administer this injection.Some common side effects of this medicine can be injection site reactions such as redness, pain or swelling. If these side effects persist for a longer duration, please consult your doctor.Before taking this medicine, tell your doctor if you have any other health conditions may be required. Inform your doctor if you are taking any other medicines or if you are pregnant or breastfeeding. It is advised not to consume alcohol after taking this medicine.
Calcium Chloride (0.070gm) + Potassium Chloride (0.038gm) + Sodium Chloride (0.85gm)
Short term fluid replacement after trauma
Gelofusine EP 0.070gm/0.038gm/0.85gm Injection is a combination of three mineral salts. Calcium Chloride, Potassium Chloride, and Sodium Chloride work together to replenish the body's fluid and electrolytes. This is how it works to treat dehydration in cases of trauma.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Injection site reactions (pain, swelling, redness)
- Alcohol : CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Gelofusine EP 0.070gm/0.038gm/0.85gm Injection. Please consult your doctor. | - Pregnancy : CONSULT YOUR DOCTOR
Gelofusine EP 0.070gm/0.038gm/0.85gm Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor. | - Breast feeding : CONSULT YOUR DOCTOR
Information regarding the use of Gelofusine EP 0.070gm/0.038gm/0.85gm Injection during breastfeeding is not available. Please consult your doctor. | - Driving : NOT RELEVANT
Not relevant, as Gelofusine EP 0.070gm/0.038gm/0.85gm Injection is intended for use in hospitalised patients. | - Kidney : CAUTION
Gelofusine EP 0.070gm/0.038gm/0.85gm Injection should be used with caution in patients with severe kidney disease. Dose adjustment of Gelofusine EP 0.070gm/0.038gm/0.85gm Injection may be needed. Please consult your doctor. | - Liver : SAFE IF PRESCRIBED
Gelofusine EP 0.070gm/0.038gm/0.85gm Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Gelofusine EP 0.070gm/0.038gm/0.85gm Injection may not be needed in these patients. Please consult your doctor.
CONSULT YOUR DOCTOR
CONSULT YOUR DOCTOR
CONSULT YOUR DOCTOR
NOT RELEVANT
CAUTION
SAFE IF PRESCRIBED
vial of 500 ml Injection
Boomerang, A601, 6th Floor, Main Chandivali Farm Road, Near Chandivali Studio, Andheri (East), 400072 Mumbai, India
India
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Mollitia iste laborum ad impedit pariatur esse optio tempora sint ullam autem deleniti nam in quos qui nemo ipsum numquam.
Add A Review
Your email address will not be published. Required fields are marked
Your Rating *
You need to Login OR Register